subscribeSubscribe
Intercept Announces FDA Acceptance of sNDA for Ocaliva

Intercept Announces FDA Acceptance of sNDA for Ocaliva
GLOBENEWSWIRE
29 Feb 2024
Share Share
Dr. Reddy`s Laboratories` Generic Obeticholic Acid Receives Approval in the U.S.

Dr. Reddy`s Laboratories` Generic Obeticholic Acid Receives Approval in the U.S.
FDA
27 Oct 2023
Share Share
Alfasigma to take over struggling Intercept

Alfasigma to take over struggling Intercept
Zoey Becker FIERCE PHARMA
27 Sep 2023
Share Share
Optimus` Generic Obeticholic Acid Receives Approval in the U.S.

Optimus` Generic Obeticholic Acid Receives Approval in the U.S.
FDA
20 Jul 2023
Share Share
Intercept restructures as NASH hopes dashed again by FDA

Intercept restructures as NASH hopes dashed again by FDA
Angus Liu FIERCE PHARMA
23 Jun 2023
Share Share
Intercept Receives Complete Response Letter from FDA for Obeticholic Acid

Intercept Receives Complete Response Letter from FDA for Obeticholic Acid
GLOBENEWSWIRE
22 Jun 2023
Share Share
MSN`s Generic Obeticholic Acid Receives Receives Approval in the U.S.

MSN`s Generic Obeticholic Acid Receives Receives Approval in the U.S.
FDA
30 May 2023
Share Share
Apotex`s Generic Obeticholic Acid Receives Receives Approval in the U.S.

Apotex`s Generic Obeticholic Acid Receives Receives Approval in the U.S.
FDA
30 May 2023
Share Share
Brain implant maker Paradromics nabs $33M, FDA breakthrough tag

Brain implant maker Paradromics nabs $33M, FDA breakthrough tag
Andrea Park FIERCE BIOTECH
19 May 2023
Share Share
Intercept Announces FDA Advisory Committee Meeting Date for Obeticholic Acid

Intercept Announces FDA Advisory Committee Meeting Date for Obeticholic Acid
GLOBENEWSWIRE
10 Mar 2023
Share Share